Coronavirus 19 Disease (COVID-19) originating in the province of Wuhan, China in 2019, is
caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), whose …

Virus-like particles (VLPs) are nanostructures that possess diverse applications in
therapeutics, immunization, and diagnostics. With the recent advancements in biomedical …

This article reviews the discovery of PCSK9, its structure–function characteristics, and its
presently known and proposed novel biological functions. The major critical function of …

Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

Controlling the global COVID-19 pandemic depends, among other measures, on developing
preventive vaccines at an unprecedented pace. Vaccines approved for use and those in …

ZBP1 is an interferon‐induced cytosolic nucleic acid sensor that facilitates antiviral
responses via RIPK3. Although ZBP1‐mediated programmed cell death is widely described …

The development of recombinant COVID-19 vaccines has resulted from scientific progress
made at an unprecedented speed during 2020. The recombinant spike glycoprotein …

Hemorrhagic Fever with Renal Syndrome (HFRS) is the most frequently diagnosed zoonosis
in Asia. This zoonotic infection is the result of exposure to the virus-contaminated aerosols …

Vaccines represent one of the most successful public health initiatives worldwide. However,
despite the vast number of highly effective vaccines, some infectious diseases still do not …

Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short
duration. We propose here that coronaviruses employ a structural strategy to avoid strong …